<DOC>
	<DOCNO>NCT01400594</DOCNO>
	<brief_summary>This multicenter , randomize , double-blind , parallel-group , placebo-controlled study HTU-520 subject clinically diagnosed onychomycosis great toenail .</brief_summary>
	<brief_title>Safety &amp; Efficacy Study HTU-520 Treatment Distal Subungual Onychomycosis Toenail</brief_title>
	<detailed_description>A Randomized , Double-Blind , Parallel-Group , Multicenter , Placebo-Controlled Study Safety &amp; Efficacy HTU-520 Treatment Mild Moderate Distal Subungual Onychomycosis Toenail</detailed_description>
	<mesh_term>Onychomycosis</mesh_term>
	<criteria>1 . Clinical diagnosis DSO least one great toenail 2 . Direct microscopy subungual debris positive hyphal element ( KOH test ) 3 . Culture confirmation growth dermatophyte 4 . Good general health 5 . Willing refrain use lotion , cream , liquid , polish treat toenail 6 . Willing refrain receiving pedicure duration study 7 . If female , use acceptable form birth control 1 . Unable apply test product onto toenail him/herself 2 . Use topical antifungal agent nail within 1 month 3 . Uncontrolled diabetes 4 . Onychomycosis fingernails 5 . Confirmed nondermatophyte infection target toenail 6 . Structural deformity target toenail , open wound , lesion , sore , surgery foot toenail 7 . History severe chronic immunosuppression , immunocompromised condition 8 . Any systemic dermatologic disorder , severe eczema , severe atopic dermatitis 9 . Psoriasis toenail 10 . Hypersensitivity allergy topical preparation ( include terbinafine ) adhesive dressing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Onychomycosis</keyword>
</DOC>